Necrotizing Fasciitis

Necrotizing fasciitis is a rapidly progressive infection of fascia and surrounding soft tissue that causes tissue necrosis and systemic toxicity. It is a surgical emergency. Antibiotics are essential but are supportive to source control; survival depends on immediate recognition and aggressive debridement.^[1] The teaching rule is absolute: when necrotizing infection is suspected, do not "try oral antibiotics and reassess tomorrow."

Necrotizing fasciitis of the leg — extensive erythema and necrosis on presentation; this is a surgical emergency, not an antibiotic-first diagnosis. (Smuszkiewicz, Trojanowska, Tomczak, CC BY 2.0, Wikimedia Commons)

• Severe pain out of proportion to visible skin findings.
• Rapid progression over hours.
• Dusky, grey, violaceous, or necrotic skin.
• Bullae, anesthesia/numbness, crepitus (subcutaneous gas), or thin foul drainage.
• Systemic toxicity, confusion, hypotension, or organ dysfunction.
• Early disease may have deceptively mild erythema — do not let a benign-looking surface mislead the assessment.

• Recent trauma, surgery, injection, or wound.
• Diabetes, vascular disease, obesity, or immunosuppression.
• Injection drug use.
• Water exposure for Vibrio/Aeromonas-type infections.
• Abdominal/perineal source for polymicrobial/Fournier gangrene.
• However, invasive group A streptococcal disease can occur without major comorbidity — do not exclude the diagnosis based on an otherwise-healthy patient.

Diagnosis is primarily clinical and operative. Laboratory scores and imaging can support assessment but must never delay surgery when suspicion is high. Obtain blood cultures and deep operative cultures when feasible — superficial swabs are insufficient. Surgical exploration confirms fascial necrosis and provides source control.^[2]

• Immediate surgical source control.
• Broad empiric antimicrobial coverage within the emergency resuscitation pathway.
• Hemodynamic stabilization and organ support.
• Narrow therapy to operative culture results once adequate coverage is established.

• Immediate aggressive surgical debridement is the definitive treatment.
• Repeat operative exploration/debridement until all necrotic tissue is removed.
• ICU-level fluid, vasopressor, and organ support as needed.
• Wound reconstruction occurs only after infection is controlled.
• Invasive group A streptococcal disease requires public-health notification and assessment of close contacts per current public-health guidance.^[3]

Pregnancy

Maternal life-saving surgery and broad IV antimicrobials take priority. Choose pregnancy-compatible agents where alternatives are equally effective, but do not delay definitive treatment for that reason.

Water exposure

Salt/brackish-water exposure raises concern for Vibrio; freshwater exposure raises concern for Aeromonas. Obtain infectious-diseases input immediately for additional Gram-negative coverage.

Fournier gangrene

Perineal necrotizing infection requires immediate urologic/general-surgical source control plus broad polymicrobial antibiotics.

Monitoring is continuous in hospital/ICU: hemodynamics, lactate/organ function, wound progression, operative findings, renal function, and antimicrobial toxicity. Lack of stabilization after initial debridement is a trigger for immediate repeat surgical assessment, not simply broader antibiotics.

1. Assume source control is incomplete until proven otherwise.
2. Return urgently to the operating room when necrosis/progression continues.
3. Review operative cultures and susceptibility.
4. Assess for a missed anatomical compartment or ongoing ischemia.
5. Optimize antimicrobial exposure with infectious-diseases/pharmacy support and organ-function-based dosing.

• Waiting for CT/MRI before calling surgery when the clinical picture is convincing.
• Trying oral antibiotics first.
• Treating antibiotics as the definitive therapy instead of debridement.
• Omitting clindamycin in suspected invasive GAS/clostridial disease.
• Using a narrow regimen before operative cultures clarify a life-threatening polymicrobial infection.

How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.

Broad empiric backbone

Toxin suppression and definitive GAS therapy

MRSA and anaerobic coverage